Top 5 Mid Cap Stocks To Own Right Now: Accuray Incorporated(ARAY)
Accuray Incorporated designs, develops, and sells medical radiation systems for the treatment of tumors anywhere in the body. The company offers the CyberKnife system, an image-guided robotic radiosurgery system used for the treatment of solid tumors. The system tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation typically with sub-millimeter accuracy. The company also offers the TomoTherapy system, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. Accuray Incorporated markets its product through a direct sales force and distributors worldwide. The company was incorporated in 1990 and is headquartered in Sunnyvale, California.
Advisors' Opinion:- [By Ben Levisohn]
Accuray (ARAY) has gained 2.7% to $9.03 after the surgical-device maker was upgraded to Overweight from Neutral at JPMorgan.
Brady (BRC) has gained 1.7% to $28.38 after it was upgraded to Buy from Underperform at Merill Lynch.
- [By John Kell]
Accuray Inc.(ARAY) shares jumped after the company posted a narrower loss than expected in its fiscal second quarter and raised its revenue estimate for the year. Shares rose 9.1% to $10.08 premarket.
- [By Alex Planes]
Intuitive Surgical's stock has been battered by worse-than-expected third-quarter results, which included the first year-over-year quarterly revenue decline in company history, coming on the heels of an underwhelming second quarter this summer. Fool contributor Rupert Hargreaves notes that the FDA's initiated an investigation on Intuitive's da Vinci surgical robotics systems, after it found several discrepancies in its incident reports. As a result, quarterly sales of the da Vinc! i declined from 155 units to 101 units, a drop that can only be partly blamed on slowing demand for medical devices in the U.S. Intuitive may have underperformed compared to recently acquired MAKO Surgical (NASDAQ: MAKO ) and Accuray (NASDAQ: ARAY ) over the past year, but it remains the 800-pound gorilla among these industry peers.
- [By Sean Williams]
What: Shares of medical device maker Accuray (NASDAQ: ARAY ) jumped as much as 13% after the company reported its third-quarter earnings results.
source from Top Stocks For 2015:http://www.topstocksblog.com/top-5-mid-cap-stocks-to-own-right-now.html
No comments:
Post a Comment